Quarter Period Statement Of Income

Carna Biosciences, Inc. - Filing #7595165

Concept 2022-01-01 to
2022-06-30
2022-01-01 to
2022-06-30
2022-01-01 to
2022-06-30
2021-01-01 to
2021-06-30
2021-01-01 to
2021-06-30
2021-01-01 to
2021-06-30
Quarter period statement of income
Statement of income
Net sales
839,543,000 JPY
553,498,000 JPY
286,045,000 JPY
430,010,000 JPY
430,010,000 JPY
JPY
Cost of sales
83,078,000 JPY
69,043,000 JPY
Gross profit (loss)
756,465,000 JPY
360,967,000 JPY
Selling, general and administrative expenses
1,068,482,000 JPY
1,138,307,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
-312,016,000 JPY
235,138,000 JPY
-547,155,000 JPY
-777,339,000 JPY
145,020,000 JPY
-922,360,000 JPY
Non-operating income
Interest income
57,000 JPY
57,000 JPY
Dividend income
204,000 JPY
198,000 JPY
Non-operating income
10,576,000 JPY
8,245,000 JPY
Non-operating expenses
Interest expenses
3,063,000 JPY
2,194,000 JPY
Non-operating expenses
4,991,000 JPY
5,637,000 JPY
Ordinary profit (loss)
-306,431,000 JPY
-774,731,000 JPY
Extraordinary losses
Impairment losses
42,948,000 JPY
6,108,000 JPY
Extraordinary losses
42,948,000 JPY
6,108,000 JPY
Profit (loss) before income taxes
-349,379,000 JPY
-780,840,000 JPY
Income taxes - current
9,802,000 JPY
1,371,000 JPY
Income taxes - deferred
-61,000 JPY
-5,739,000 JPY
Income taxes
9,740,000 JPY
-4,367,000 JPY
Profit (loss)
-359,120,000 JPY
-776,472,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.